These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 14769338

  • 1. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS, Hergenrother PJ.
    Anal Biochem; 2004 Mar 01; 326(1):78-86. PubMed ID: 14769338
    [Abstract] [Full Text] [Related]

  • 2. A scintillation proximity assay for poly(ADP-ribose) polymerase.
    Cheung A, Zhang J.
    Anal Biochem; 2000 Jun 15; 282(1):24-8. PubMed ID: 10860495
    [Abstract] [Full Text] [Related]

  • 3. A FlashPlate assay for the identification of PARP-1 inhibitors.
    Dillon KJ, Smith GC, Martin NM.
    J Biomol Screen; 2003 Jun 15; 8(3):347-52. PubMed ID: 12857389
    [Abstract] [Full Text] [Related]

  • 4. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A, Schemainda I, Pelka-Fleischer R, Nüssler V, Hasmann M.
    Eur J Med Res; 2003 Oct 22; 8(10):438-50. PubMed ID: 14594650
    [Abstract] [Full Text] [Related]

  • 5. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.
    Putt KS, Hergenrother PJ.
    Anal Biochem; 2004 Oct 15; 333(2):256-64. PubMed ID: 15450800
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells.
    Kehe K, Raithel K, Kreppel H, Jochum M, Worek F, Thiermann H.
    Arch Toxicol; 2008 Jul 15; 82(7):461-70. PubMed ID: 18046540
    [Abstract] [Full Text] [Related]

  • 7. Development of a miniaturized assay for the high-throughput screening program for poly(ADP-ribose) polymerase-1.
    Lee S, Koo HN, Lee BH.
    Methods Find Exp Clin Pharmacol; 2005 Nov 15; 27(9):617-22. PubMed ID: 16357945
    [Abstract] [Full Text] [Related]

  • 8. An improved nonisotopic test to screen a large series of new inhibitor molecules of poly(ADP-ribose) polymerase activity for therapeutic applications.
    Decker P, Miranda EA, de Murcia G, Muller S.
    Clin Cancer Res; 1999 May 15; 5(5):1169-72. PubMed ID: 10353753
    [Abstract] [Full Text] [Related]

  • 9. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism.
    Bakondi E, Bai P, Erdélyi K, Szabó C, Gergely P, Virág L.
    Exp Dermatol; 2004 Mar 15; 13(3):170-8. PubMed ID: 14987257
    [Abstract] [Full Text] [Related]

  • 10. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
    Tramontano F, Malanga M, Quesada P.
    Mol Hum Reprod; 2007 Nov 15; 13(11):821-8. PubMed ID: 17766683
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
    Okita N, Ashizawa D, Ohta R, Abe H, Tanuma S.
    Biochem Biophys Res Commun; 2010 Feb 19; 392(4):485-9. PubMed ID: 20079708
    [Abstract] [Full Text] [Related]

  • 13. The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells.
    Marecki JC, McCord JM.
    Arch Biochem Biophys; 2002 Jun 15; 402(2):227-34. PubMed ID: 12051667
    [Abstract] [Full Text] [Related]

  • 14. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T, Shymanskyy I, Donchenko G, Kuchmerovskyy M, Pakirbaieva L, Klimenko A.
    J Diabetes Complications; 2004 Jun 15; 18(4):198-204. PubMed ID: 15207836
    [Abstract] [Full Text] [Related]

  • 15. Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells.
    Mahrouf-Yorgov M, Marie N, Borderie D, Djelidi R, Bonnefont-Rousselot D, Legrand A, Beaudeux JL, Peynet J.
    Metabolism; 2009 Apr 15; 58(4):525-33. PubMed ID: 19303974
    [Abstract] [Full Text] [Related]

  • 16. Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.
    Gerö D, Módis K, Nagy N, Szoleczky P, Tóth ZD, Dormán G, Szabó C.
    Int J Mol Med; 2007 Nov 15; 20(5):749-61. PubMed ID: 17912470
    [Abstract] [Full Text] [Related]

  • 17. Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation.
    Fossati S, Cipriani G, Moroni F, Chiarugi A.
    Neurochem Int; 2007 Jan 15; 50(1):203-10. PubMed ID: 17052800
    [Abstract] [Full Text] [Related]

  • 18. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.
    Horvath EM, Szabó C.
    Drug News Perspect; 2007 Apr 15; 20(3):171-81. PubMed ID: 17520094
    [Abstract] [Full Text] [Related]

  • 19. Different basal NAD levels determine opposite effects of poly(ADP-ribosyl)polymerase inhibitors on H2O2-induced apoptosis.
    Coppola S, Nosseri C, Maresca V, Ghibelli L.
    Exp Cell Res; 1995 Dec 15; 221(2):462-9. PubMed ID: 7493646
    [Abstract] [Full Text] [Related]

  • 20. NAD(+) consumption in carcinogen-treated hamster cells overexpressing a dominant negative mutant of poly(ADP-ribose) polymerase.
    Küpper JH, Müller M, Wolf I.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):525-9. PubMed ID: 10558902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.